May 21, 2020 / 6:12 AM / 16 days ago

BRIEF-Takara Bio Selects AGC Biologics As Manufacturer Of Plasmid DNA Intermediate For A Vaccine Against COVID-19

May 21 (Reuters) - AGC Biologics:

* TAKARA BIO SELECTS AGC BIOLOGICS AS MANUFACTURER OF PLASMID DNA INTERMEDIATE FOR A VACCINE AGAINST COVID-19 (SARS-COV-2)

* AGC BIOLOGICS - PARTNERSHIP WITH TAKARA BIO BY COLLABORATING ON PROPHYLAXIS DNA VACCINE, WITH AGC MANUFACTURING PLASMID DNA INTERMEDIATE FOR VACCINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below